Massachusetts voters confront a potentially historic cannabis rollback, High Tide expands its Canadian retail footprint, and Nicolas Cage’s dispute with Amazon puts Hollywood’s AI consent battle back in focus.
Tag: Entertainment Business
Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy
Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.
Cannabis Growth Meets Tougher Enforcement as Hollywood Consolidates
New York posted record quarterly cannabis sales, Michigan revoked a retailer’s license over serious compliance violations, and Paramount set an expected closing date for its Warner Bros. Discovery acquisition.
Cannabis Oversight Shifts as Safety and Scale Drive the News
Canada is considering a major reduction in cannabis reporting requirements, while Colorado regulators warn consumers about contaminated vape products sold statewide. In entertainment, Universal became the first studio to cross $5 billion at the 2026 global box office.
Hemp Sales Face New Limits as Cannabis Oversight Draws Scrutiny
A federal appeals court narrowed protections for hemp sellers in Ohio, an Atlantic City official faces cannabis-related bribery charges, and bipartisan lawmakers proposed a major federal incentive for domestic film and television production.
Cannabis Capital Risks Rise as Paramount Deal Hits a Judicial Pause
Two cannabis lawsuits spotlight financing and data-security risks for licensed retailers, while a federal judge delays approval of the settlement intended to clear Paramount’s Warner Bros. Discovery acquisition.
Cannabis Contract Shock and Hollywood’s Merger Standoff
A federal appeals court erased a $31.8 million cannabis verdict, Ohio activated detailed product rules, and Paramount’s contested Warner Bros. acquisition moved toward court-ordered settlement talks.
